PLCE1 and esophageal squamous cell carcinoma: These data suggest that epigenetically upregulated oncoprotein PLCE1 can activate the NF-κB signaling pathway and may promote angiogenesis and cause poor clinical outcomes in ESCC (Fig. 7e).